| Autor: |
Leineweber FV; Instituto de Tecnologia em Fármacos, Farmanguinhos, Fundação Oswaldo Cruz (Fiocruz). R. Sizenando Nabuco 100, Manguinhos. 21041-250 Rio de Janeiro RJ Brasil. fabius.leineweber@far.fiocruz.br., Bermudez JAZ; Escola Nacional de Saúde Pública Sérgio Arouca, Fiocruz. Rio de Janeiro RJ Brasil. |
| Jazyk: |
Portuguese; English |
| Zdroj: |
Ciencia & saude coletiva [Cien Saude Colet] 2021 Mar; Vol. 26 (3), pp. 1001-1012. Date of Electronic Publication: 2020 Nov 23. |
| DOI: |
10.1590/1413-81232021263.38042020 |
| Abstrakt: |
The American response to the pandemic involves a prominent volume of federal resources, especially for developing and acquiring products for internal use, such as diagnostics or vaccines. Investment mechanisms and historical aspects justify this expenditure. Thus, the social construction of nationalism in American society hinders access to health technologies. The review of such aspects shows how the United States (U.S.) secured a large number of potential products, ensuring excessive local production. This unilateral foreign policy has influenced other countries or regional blocs and undermined global cooperation and solidarity, affecting the collective health of several nations. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
